Evaluation of type I error rates when modeling ordered categorical data in NONMEM

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 31, Issue 1, 2004, Pages 61-74

  Wählby, Ulrika ^a   Matolcsi, Katalin ^a   O Karlsson, Mats ^a   Jonsson, E Niclas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

likelihood ratio test; logistic regression; mixed effects modeling

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CALCULATION; DRUG EFFECT; DRUG EXPOSURE; EVALUATION; MODEL; PARAMETER; PRIORITY JOURNAL; RANDOMIZATION; SIMULATION; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

CLINICAL TRIALS; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; NONLINEAR DYNAMICS; PHARMACOKINETICS; PHARMACOLOGY; RESEARCH DESIGN;

EID: 18544404948     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOPA.0000029489.97168.a9     Document Type: Article

References (17)

1. A. Agresti. Modelling ordered categorical data: Recent advances and future challenges. Stat. Med. 18:2191-2207 (1999).
2. L. B. Sheiner. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin. Pharmacol. Ther. 56:309-322 (1994).
3. L. B. Sheiner, S.L. Beal, and A. Dunne. Analysis of non-randomly censored ordered categorical longitudinal data from analgesic trials. J. Am. Stat. Assoc. 92:1235-1255 (1997).
4. S. L. Beal and L. B. Sheiner. NONMEM Users Guide. NONMEM project group, University of California, San Francisco, 1998.
5. J. W. Mandema and D. R. Stanski. Population pharmacodynamic model for ketorolac analgesia, Clin. Pharmacol. Ther. 60: 619-635 (1996).
6. S. K. Gupta, G. Sathyan, E. A. Lindemulder, P. L. Ho, L. B. Sheiner, and L. Aarons. Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships. Clin. Pharmacol. Ther. 65:672-684 (1999).
7. R. Gomeni, V. Teneggi, L. Iavarone, L. Squassante, and A. Bye. Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: Indirect response and probabilistic modeling. Pharm. Res. 18:537-543 (2001).
8. D. R. Mould, N. H. Holford, J. H. Schellens, J. H. Beijnen, P. R. Hutson, H. Rosing, W. W. ten Bokkel Huinink, E. K. Rowinsky, J. H. Schiller, M. Russo, and G. Ross. Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors. Clin. Pharmacol. Ther. 71:334-348 (2002).
9. S. L. Beal and L. B. Sheiner. Estimating population kinetics. Crit. Rev. Biomed. Eng. 8:195-222 (1982).
10. M. Davidian and D. M. Giltinan. Nonlinear models for repeated measurement data. In Monographs on Statistics and Applied Probability 62, D.R. Cox (ed.) Chapman & Hall, London, 1995.
11. S. L. Beal. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. Drug. Metab. Rev. 15:173-193 (1984).
12. U. Wahlby, E. N. Jonsson, and M. O. Karlsson. Assessment of actual significance levels for covariate effects in NONMEM. J. Pharmacokinet. Pharmacodyn. 28:231-252 (2001).
13. U. Wahlby, M. R. Bouw, E. N. Jonsson, and M. O. Karlsson. Assessment of type I error rates for the statistical sub-model in NONMEM. J. Pharmacokinet. Pharmacodyn. 29:251-269 (2002).
14. D. O. Stram and J. W. Lee. Variance components testing in the longitudinal mixed effects model. Biometrics 50:1171-1177 (1994).
15. J. C. Pinheiro and D. M. Bates. Mixed-effects Models in S and S-PLUS. Springer-Verlag, New York, 2000.
16. I. Yano, S. L. Beal, and L. B. Sheiner. The need for mixed-effects modeling with population dichotomous data. J. Pharmacokinet. Pharmacodyn. 28:389-412 (2001).
17. S. Jönsson and M. O. Karlsson. Estimating bias in parameters for some NONMEM models for ordered categorical data. In 11th PAGE Meeting, Paris, 2002.